ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 13 Mar 2023
Last Applicant/ Owned by
Barnahely
Ringaskiddy, Co. Cork
IE
Serial Number
88563238 filed on 02th Aug 2019
Registration Number
N/A
Correspondent Address
Cheryl L Foytlin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ORMEDLI
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory dis Read More
Classification Information
Class [005]
Pharmaceutical Products
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Mark Details
Serial Number
No 88563238
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T40542US2
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Mar 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 13th Mar 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 11th Aug 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th Aug 2022 | SOU EXTENSION 5 GRANTED |
| 10th Aug 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 29th Jul 2022 | SOU EXTENSION 5 FILED |
| 29th Jul 2022 | TEAS EXTENSION RECEIVED |
| 02th Feb 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 01st Feb 2022 | ASSIGNED TO EXAMINER |
| 31st Jan 2022 | SOU EXTENSION 4 GRANTED |